American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
暂无分享,去创建一个
W. Chey | B. C. Wong | B. Wong
[1] M. Blaser,et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. , 1995, Gastroenterology.
[2] A. Berstad,et al. Reproducibility of the 14C urea breath test repeated after 1 week. , 1995, The American journal of gastroenterology.
[3] F. Mégraud,et al. Diagnosis of Helicobacter pylori Infection , 2006, Helicobacter.
[4] L. Irwig,et al. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. , 1996, The American journal of gastroenterology.
[5] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[6] L. Laine,et al. Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. , 1996, Gastrointestinal endoscopy.
[7] D. Graham,et al. The Best Gastric Site for Obtaining a Positive Rapid Urease Test , 1996, Helicobacter.
[8] C. O'Morain,et al. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. , 1997, Scandinavian journal of gastroenterology.
[9] W. Chey,et al. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism. , 1997, The American journal of gastroenterology.
[10] A. Blum,et al. Lack of Effect of TreatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia , 1998 .
[11] R. Knill-Jones,et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. , 1998, The New England journal of medicine.
[12] Effect of standard and high dose ranitidine on [13c]urea breath test results , 1998 .
[13] L. Laine,et al. Effect of Proton-Pump Inhibitor Therapy on Diagnostic Testing for Helicobacter pylori , 1998, Annals of Internal Medicine.
[14] N. Talley. American Gastroenterological Association medical position statement: evaluation of dyspepsia. , 2005, Gastroenterology.
[15] R. Hunt,et al. Guidelines for the management of Helicobacter pylori infection , 1998, American Journal of Gastroenterology.
[16] E. Brooks,et al. Effect of Standard and High Dose Ranitidine on [13C]Urea Breath Test Results , 1998, American Journal of Gastroenterology.
[17] P. Malfertheiner,et al. Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting , 1999, American Journal of Gastroenterology.
[18] F. Gomollón,et al. Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1‐week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer , 1999, Alimentary pharmacology & therapeutics.
[19] W. Chey,et al. The 13C-urea blood test accurately detects active Helicobacter pylori infection: a United States, multicenter trial , 1999, American Journal of Gastroenterology.
[20] F. Mandelli,et al. Reversal of Iron Deficiency Anemia after Helicobacter pylori Eradication in Patients with Asymptomatic Gastritis , 1999, Annals of Internal Medicine.
[22] W. Chey,et al. A comparison of three fingerstick, whole blood antibody tests for Helicobacter pylori infection: a United States, multicenter trial , 1999, American Journal of Gastroenterology.
[23] S. Kim,et al. Randomized Placebo‐Controlled Trial of Helicobacter pylori Eradication for Iron‐Deficiency Anemia in Preadolescent Children and Adolescents , 1999, Helicobacter.
[24] Shih-hung Huang,et al. Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers. , 1999, Gastrointestinal endoscopy.
[25] L. Bravo,et al. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection , 1999, American Journal of Gastroenterology.
[26] Colin-Jones Dg,et al. Guidelines for the management of dyspepsia. , 1999 .
[27] L. Laine,et al. Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori. , 2000, Gastrointestinal endoscopy.
[28] Hoffman,et al. Furazolidone combination therapies for Helicobacter pylori infection in the United States , 2000, Alimentary pharmacology & therapeutics.
[29] H. Windsor,et al. Accurate diagnosis of Helicobacter pylori. Polymerase chain reaction tests. , 2000, Gastroenterology clinics of North America.
[30] N. Lehn,et al. Rifabutin-based Triple Therapy After Failure of Helicobacter pylori Eradication Treatment: Preliminary Experience , 2000, Journal of clinical gastroenterology.
[31] G. Perez-Perez,et al. Accurate diagnosis of Helicobacter pylori. Culture, including transport. , 2000, Gastroenterology clinics of North America.
[32] H. El-Zimaity. Accurate diagnosis of Helicobacter pylori with biopsy. , 2000, Gastroenterology clinics of North America.
[33] B. Marshall,et al. Accurate diagnosis of Helicobacter pylori. Urease tests. , 2000, Gastroenterology clinics of North America.
[34] N. Vakil,et al. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori , 2000, American Journal of Gastroenterology.
[35] A. Andriulli,et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. , 2000, The New England journal of medicine.
[36] F. Mégraud,et al. HOW TO TREAT HELICOBACTER PYLORI , 2000 .
[37] D. Metz,et al. Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infection , 2000, American Journal of Gastroenterology.
[38] C. O'Morain,et al. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding , 2000, American Journal of Gastroenterology.
[39] F. Mégraud,et al. How to treat Helicobacter pylori. First-line, second-line, and future therapies. , 2000, Gastroenterology clinics of North America.
[40] B. Marshall,et al. Accurate diagnosis of Helicobacter pylori. Serologic testing. , 2000, Gastroenterology clinics of North America.
[41] H. Windsor,et al. ACCURATE DIAGNOSIS OF HELICOBACTER PYLOXI , 2000 .
[42] A. Fendrick,et al. Helicobacter pylori-related disease: guidelines for testing and treatment. , 2000, Archives of internal medicine.
[43] W. Chey. Accurate diagnosis of Helicobacter pylori. 14C-urea breath test. , 2000, Gastroenterology clinics of North America.
[44] D. Graham,et al. Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. , 2000, Gastroenterology clinics of North America.
[45] Gené,et al. A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection , 2000, Alimentary pharmacology & therapeutics.
[46] J. Everhart. Recent developments in the epidemiology of Helicobacter pylori. , 2000, Gastroenterology clinics of North America.
[47] Appropriate timing of the 14C-urea breath test to establish eradication of Helicobacter pylori infection , 2000 .
[48] S. Vigneri,et al. Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori , 2001, American Journal of Gastroenterology.
[49] W. Chey,et al. Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. , 2001, Archives of internal medicine.
[50] P. Malfertheiner,et al. A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer , 2001, Alimentary pharmacology & therapeutics.
[51] F. Chan,et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.
[52] A. Andriulli,et al. Randomized study of two “rescue” therapies for helicobacter pylori-infected patients after failure of standard triple therapies , 2001, American Journal of Gastroenterology.
[53] N. Sato,et al. Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. , 2001, Scandinavian journal of gastroenterology.
[54] A. Sahai,et al. Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage , 2001, Alimentary pharmacology & therapeutics.
[55] J. Casellas,et al. Comparison of diagnostic methods for Helicobacter pylori infection in patients with upper gastrointestinal bleeding. , 2001, Scandinavian journal of gastroenterology.
[56] R. E. Smith,et al. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. , 2001, Ophthalmology.
[57] C. Soussy,et al. Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy , 2001, Alimentary pharmacology & therapeutics.
[58] P. Hsu,et al. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer‐like functional dyspepsia , 2001, Alimentary pharmacology & therapeutics.
[59] M. Färkkilä,et al. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia , 2001, American Journal of Gastroenterology.
[60] G. Manes,et al. Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy , 2001, Alimentary pharmacology & therapeutics.
[61] B. Burnand,et al. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia , 2001, American Journal of Gastroenterology.
[62] N. Talley,et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. , 2002, Gastroenterology.
[63] C. O'Morain,et al. Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5‐Year Follow‐Up Study , 2002, Helicobacter.
[64] F. Nomura,et al. Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy , 2002, American Journal of Gastroenterology.
[65] R. Hopkins,et al. Recovery Rate and Prognosis in Older Persons Who Develop Acute Lung Injury and the Acute Respiratory Distress Syndrome , 2002, Annals of Internal Medicine.
[66] K. Lai,et al. One‐week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies , 2002, Alimentary pharmacology & therapeutics.
[67] L. Laine,et al. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies , 2002, American Journal of Gastroenterology.
[68] R. Hopkins,et al. Risk Factors for Helicobacter pylori Resistance in the United States: The Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 19931999 , 2002, Annals of Internal Medicine.
[69] P. Hsu,et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients , 2002, Gut.
[70] F. Perri,et al. Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments , 2002, American Journal of Gastroenterology.
[71] I. Maev,et al. Furazolidone‐based triple ‘rescue therapy’ vs. quadruple ‘rescue therapy’ for the eradication of Helicobacter pylori resistant to metronidazole , 2002, Alimentary pharmacology & therapeutics.
[72] P. Malfertheiner,et al. Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report , 2002, Alimentary pharmacology & therapeutics.
[73] J. Gisbert,et al. The Stool Antigen Test for Detection of Helicobacter pylori after Eradication Therapy , 2002, Annals of Internal Medicine.
[74] R. Hunt,et al. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis , 2002, The Lancet.
[75] J. Gisbert,et al. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta‐analysis , 2002, Alimentary pharmacology & therapeutics.
[76] D. Graham,et al. Pearls and pitfalls of assessing Helicobacter pylori status. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[77] D. Forman,et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews , 2003, American Journal of Gastroenterology.
[78] D. Graham,et al. Meta‐analysis: proton pump inhibitor or H2‐receptor antagonist for Helicobacter pylori eradication , 2003, Alimentary pharmacology & therapeutics.
[79] F. Mégraud,et al. Review article: the treatment of refractory Helicobacter pylori infection , 2003, Alimentary pharmacology & therapeutics.
[80] D. Schilling,et al. A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[81] D. Graham,et al. Salvage Therapy after Two or More Prior Helicobacter pylori Treatment Failures: the Super Salvage Regimen , 2003, Helicobacter.
[82] L. Laine. Is it time for quadruple therapy to be first line? , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[83] G. Apseloff. Severe neutropenia among healthy volunteers given rifabutin in clinical trials , 2003, Clinical pharmacology and therapeutics.
[84] B. McMahon,et al. The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections , 2003, Annals of Internal Medicine.
[85] F. Mégraud,et al. Which Test to Use to Detect Helicobacter pylori Infection in Patients With Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma? , 2003, American Journal of Gastroenterology.
[86] C. Hassan,et al. High eradication rates of Helicobacter pylori with a new sequential treatment , 2003, Alimentary pharmacology & therapeutics.
[87] G. Gatz,et al. Recent Use of Proton Pump Inhibitor‐Based Triple Therapies for the Eradication of H. pylori: A Broad Data Review , 2003, Helicobacter.
[88] Lack of accuracy of the noninvasive stool antigen test in patients with gastroduodenal ulcer bleeding , 2003 .
[89] W. Wong,et al. Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection , 2003, Alimentary pharmacology & therapeutics.
[90] Is it time for quadruple therapy to be first line , 2003 .
[91] K. Haruma,et al. The long‐term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis , 2003, Alimentary pharmacology & therapeutics.
[92] P. Malfertheiner,et al. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia , 2003, Alimentary pharmacology & therapeutics.
[93] J. Aparicio,et al. Comparison of stool immunoassay with standard methods for detection of Helicobacter pylori infection in patients with upper‐gastrointestinal bleeding of peptic origin , 2003, European journal of gastroenterology & hepatology.
[94] A. Gasbarrini,et al. Meta‐analysis: the relationship between Helicobacter pylori infection and gastro‐oesophageal reflux disease , 2003, Alimentary pharmacology & therapeutics.
[95] R. Hunt,et al. Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A , 2003, American Journal of Gastroenterology.
[96] J. Gisbert,et al. Meta‐analysis: comparative efficacy of different proton‐pump inhibitors in triple therapy for Helicobacter pylori eradication , 2003, Alimentary pharmacology & therapeutics.
[97] D. Graham,et al. Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies , 2003, Helicobacter.
[98] J. Gisbert,et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. , 2003, The Cochrane database of systematic reviews.
[99] X. Calvet,et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis , 2003, Alimentary pharmacology & therapeutics.
[100] Chia‐Long Lee,et al. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. , 2003, Archives of internal medicine.
[101] A. Hungin,et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review , 2003, BMJ : British Medical Journal.
[102] P. Malfertheiner,et al. Antigen stool test for assessment of Helicobacter pylori infection in patients with upper gastrointestinal bleeding , 2003, Alimentary pharmacology & therapeutics.
[103] D. Graham,et al. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors , 2003, American Journal of Gastroenterology.
[104] L. Cohen,et al. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia , 2003, American Journal of Gastroenterology.
[105] G. Tytgat,et al. Lack of Accuracy of the Noninvasive Helicobacter pylori Stool Antigen Test in Patients With Gastroduodenal Ulcer Bleeding , 2003, American Journal of Gastroenterology.
[106] J. Gisbert,et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta‐analysis , 2003, Alimentary pharmacology & therapeutics.
[107] F. Perna,et al. Effect of Proton Pump Inhibitors and Antacid Therapy on 13C Urea Breath Tests and Stool Test for Helicobacter Pylori Infection , 2004, American Journal of Gastroenterology.
[108] A. Barkun,et al. There is no difference in the disease severity of gastro‐oesophageal reflux disease between patients infected and not infected with Helicobacter pylori , 2004, Alimentary pharmacology & therapeutics.
[109] M. Granström,et al. Enzyme-Linked Immunosorbent Assay for Helicobacter pylori Needs Adjustment for the Population Investigated , 2004, Journal of Clinical Microbiology.
[110] HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE IN CANADIAN POPULATIONS , 2004 .
[111] D. Levine,et al. Symptom Response and Healing of Erosive Esophagitis with Proton-Pump Inhibitors in Patients with Helicobacter pylori Infection , 2004, American Journal of Gastroenterology.
[112] M. Sasatsu,et al. Development of a Highly Sensitive Method for Detection of Clarithromycin-Resistant Helicobacter pylori from Human Feces , 2005, Current Microbiology.
[113] J. Gisbert,et al. Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer , 2004 .
[114] Abdulmajeed Al Abdukareem. Randomized, placebo-controlled trial , 2004, Annals of Saudi medicine.
[115] N. Vakil,et al. Seven‐day therapy for Helicobacter pylori in the United States , 2004, Alimentary pharmacology & therapeutics.
[116] D. Forman,et al. Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis , 2004, The American Journal of Gastroenterology.
[117] A. Çelebi,et al. Improvement of complete blood count in patients with iron deficiency anemia and Helicobacter pylori infection after the eradication of Helicobacter pylori. , 2004, Hepato-gastroenterology.
[118] J. Lee,et al. (Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China.) , 2004 .
[119] A. Smout,et al. Treatment of gastro‐oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness? , 2004, Alimentary pharmacology & therapeutics.
[120] L. Fischbach,et al. Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies , 2004, Alimentary pharmacology & therapeutics.
[121] Y. Ou,et al. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers , 2004, Helicobacter.
[122] J. Gisbert,et al. Review article: 13C‐urea breath test in the diagnosis of Helicobacter pylori infection – a critical review , 2004, Alimentary pharmacology & therapeutics.
[123] F. Chan,et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication , 2004, Gut.
[124] D. Graham,et al. False Negative Urea Breath Tests with H2‐Receptor Antagonists: Interactions Between Helicobacter pylori Density and pH , 2004, Helicobacter.
[125] J. Pandolfino,et al. H. Pylori and GERD: Is Less More? , 2004, American Journal of Gastroenterology.
[126] D. Metz,et al. Antimicrobial Resistance Incidence and Risk Factors among Helicobacter pylori–Infected Persons, United States , 2004, Emerging infectious diseases.
[127] J. Gisbert,et al. Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: a Systematic Review , 2004, Helicobacter.
[128] D. Graham,et al. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[129] J. Sung. Should we eradicate Helicobacter pylori in non‐steroidal anti‐inflammatory drug users? , 2004, Alimentary pharmacology & therapeutics.
[130] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[131] B. Ali. Pharmacological, Therapeutic and Toxicological Properties of Furazolidone: Some Recent Research , 1999, Veterinary Research Communications.
[132] S. Childs,et al. The effect of Helicobacter pylori and its eradication on gastro‐oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis , 2004, Alimentary pharmacology & therapeutics.
[133] D. Kearney,et al. Iron-Deficiency Anemia and Helicobacter pylori Infection: A Review of the Evidence , 2005, The American Journal of Gastroenterology.
[134] R. Owen,et al. Real-time PCR detection and frequency of 16 S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales , 2005 .
[135] R. Laheij,et al. The importance of corpus biopsies for the determination of Helicobacter pylori infection. , 2005, The Netherlands journal of medicine.
[136] G. Papatheodoridis,et al. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. , 2005, World journal of gastroenterology.
[137] M. Stolte,et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] W. Chey,et al. A clinician's guide to managing Helicobacter pylori infection. , 2005, Cleveland Clinic journal of medicine.
[139] R. Gascoyne,et al. Helicobacter pylori and MALT lymphoma. , 2005, Gastroenterology.
[140] P. Malfertheiner,et al. Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique , 2005, The American Journal of Gastroenterology.
[141] M. Janssen,et al. Meta‐analysis: the influence of pre‐treatment with a proton pump inhibitor on Helicobacter pylori eradication , 2005, Alimentary pharmacology & therapeutics.
[142] C. Hassan,et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study , 2005, Alimentary pharmacology & therapeutics.
[143] E. Cholongitas,et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. , 2005, World journal of gastroenterology.
[144] C. O'Morain,et al. Rifabutin‐ and furazolidone‐based Helicobacter pylori eradication therapies after failure of standard first‐ and second‐line eradication attempts in dyspepsia patients , 2005, Alimentary pharmacology & therapeutics.
[145] J. Gisbert,et al. Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users , 2005, Alimentary pharmacology & therapeutics.
[146] M. Passos,et al. New once‐daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study , 2005, Alimentary pharmacology & therapeutics.
[147] P. Toskes,et al. Evaluation of the Ez‐HBT Helicobacter blood test to establish Helicobacter pylori eradication , 2005, Alimentary pharmacology & therapeutics.
[148] Geun Ho Kang,et al. Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults , 2005, Antimicrobial Agents and Chemotherapy.
[149] E. Fontham,et al. Long term follow up of patients treated for Helicobacter pylori infection , 2005, Gut.
[150] H. Matsumoto,et al. Long‐term clinical outcome of Helicobacter pylori eradication for gastric mucosa‐associated lymphoid tissue lymphoma with a reference to second‐line treatment , 2005, Cancer.
[151] N. Talley,et al. Guidelines for the Management of Dyspepsia , 2005, The American Journal of Gastroenterology.
[152] J. J. Tai,et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. , 2005, Journal of the National Cancer Institute.
[153] A. Francavilla,et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. , 2005, Gastroenterology.
[154] F. Chan. NSAID-Induced Peptic Ulcers and Helicobacter pylori Infection , 2005, Drug safety.
[155] R. Owen,et al. Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales. , 2005, The Journal of antimicrobial chemotherapy.
[156] F. Mégraud,et al. Should We Eradicate Helicobacter pylori Before Prescribing an NSAID? Result of a Placebo-Controlled Study , 2005, The American Journal of Gastroenterology.
[157] L. Laine,et al. The effect of GI bleeding on Helicobacter pylori diagnostic testing: a prospective study at the time of bleeding and 1 month later. , 2005, Gastrointestinal endoscopy.
[158] F. Perna,et al. Diagnostic accuracy of a new rapid urease test (Pronto Dry), before and after treatment of Helicobacter pylori infection. , 2005, Minerva gastroenterologica e dietologica.
[159] R. Testa,et al. A study of 4‐ and 7‐day triple therapy with rabeprazole, high‐dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication , 2006, Alimentary pharmacology & therapeutics.
[160] A. Opekun,et al. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas‐Mexican border , 2006, Alimentary pharmacology & therapeutics.
[161] L. Marzio,et al. Role of the Preliminary Susceptibility Testing for Initial and After Failed Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and Esomeprazole , 2006, Helicobacter.
[162] J. Gisbert,et al. Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures , 2006, The American Journal of Gastroenterology.
[163] J. Gisbert,et al. Accuracy of Monoclonal Stool Antigen Test for the Diagnosis of H. pylori Infection: A Systematic Review and Meta-Analysis , 2006, The American Journal of Gastroenterology.
[164] B. Gessner,et al. Endemic Iron Deficiency Associated With Helicobacter pylori Infection Among School-Aged Children in Alaska , 2006, Pediatrics.
[165] M. Kasuga,et al. Primary Levofloxacin Resistance and gyrA/B Mutations Among Helicobacter pylori in Japan , 2006, Helicobacter.
[166] R. Hunt,et al. The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis , 2006, The American Journal of Gastroenterology.
[167] J. Gisbert,et al. Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure , 2006, Alimentary pharmacology & therapeutics.
[168] F. Perna,et al. Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial , 2005, Gut.
[169] J. Sánchez-Delgado,et al. Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer , 2006, Alimentary pharmacology & therapeutics.
[170] F. Norman,et al. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond , 2006, Expert review of anticancer therapy.
[171] T. Borody,et al. Efficacy and safety of rifabutin‐containing ‘rescue therapy’ for resistant Helicobacter pylori infection , 2006, Alimentary pharmacology & therapeutics.
[172] Víctor Abraira,et al. Accuracy of Helicobacter pylori Diagnostic Tests in Patients with Bleeding Peptic Ulcer: A Systematic Review and Meta-analysis , 2006, The American Journal of Gastroenterology.
[173] M. Stolte,et al. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro‐oesophageal reflux disease in Western patients with non‐ulcer dyspepsia , 2006, Alimentary pharmacology & therapeutics.
[174] C. Hassan,et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real‐time polymerase chain reaction , 2006, Alimentary pharmacology & therapeutics.
[175] G. Papatheodoridis,et al. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[176] K. Matsuo,et al. Systematic review and meta‐analysis: importance of CagA status for successful eradication of Helicobacter pylori infection , 2006, Alimentary pharmacology & therapeutics.
[177] K. Gebo. Implications for Patient Management , 2006 .
[178] C. Hassan,et al. Clarithromycin-Resistant Genotypes and Eradication of Helicobacter pylori , 2006, Annals of Internal Medicine.
[179] Ziding Feng,et al. A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska. , 2006, The Journal of infectious diseases.
[180] R. Meier,et al. Increased Rate of Helicobacter pylori Infection Detected by PCR in Biopsies With Chronic Gastritis , 2006, The American journal of surgical pathology.
[181] W. Chey,et al. Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis , 2006, The American Journal of Gastroenterology.
[182] M. Stolte,et al. Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin , 2006, Alimentary pharmacology & therapeutics.
[183] C. Hassan,et al. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[184] W. Chey,et al. Primary care physician perceptions of non‐steroidal anti‐inflammatory drug and aspirin‐associated toxicity: results of a national survey , 2006, Alimentary pharmacology & therapeutics.
[185] F. Nardi,et al. 2‐Week Triple Therapy for Helicobacter pylori Infection is Better Than 1‐Week in Clinical Practice: a Large Prospective Single‐Center Randomized Study , 2006, Helicobacter.
[186] D. Forman,et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. , 2006, The Cochrane database of systematic reviews.
[187] Y. Glupczynski,et al. Prevalence and Mechanisms of Resistance to Fluoroquinolones in Helicobacter pylori Strains from Patients Living in Belgium , 2006, Helicobacter.
[188] D. Graham,et al. Iron deficiency and Helicobacter pylori infection in the United States. , 2006, American journal of epidemiology.
[189] T Rokkas,et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.